title: Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis.
abstract: BACKGROUND
  Hemodialysis (HD) patients are exposed to oxidative stress which contributes to cardiovascular disease (CVD). The purpose of this study was to investigate the oxidative and antioxidative status in HD patients with (CVD+, n = 38) and without (CVD-, n = 67) prevalent CVD.
  
  
  METHODS
  A total of 105 HD patients and 21 healthy controls were assessed for lipid peroxidation indices (plasma malondialdehyde (MDA)), oxidizability of apolipoprotein B-containing lipoproteins (apo B-deltaMDA) and red blood cells (RBC-MDA) together with various components of the antioxidant system in plasma (paraoxonase/arylesterase activities, total carotenoids, vitamins C and E) and RBC (superoxide dismutase and glutathione peroxidase activities).
  
  
  RESULTS
  Plasma MDA and RBC-MDA were significantly higher, vitamin C and total carotenoid levels were significantly lower in both CVD+ and CVD- HD groups than in the control group. Plasma MDA levels were significantly higher and serum paraoxonase activity, uric acid and albumin levels were significantly lower in patients with CVD+ HD patients compared to those of the CVD- patients.
  
  
  CONCLUSIONS
  This study suggests that the elevated level of plasma MDA and the lower activity of paraoxonase could contribute to the increased incidence of cardiovascular disease in hemodialysis patients.
authors.affiliation: Department of Biochemistry, Medical Faculty of Uludag University, Bursa, Turkey. mdirican@uludag.edu.tr
authors.forename: M
authors.initials: M
authors.lastname: Dirican
authors.forename: E
authors.initials: E
authors.lastname: Sarandol
authors.forename: Z
authors.initials: Z
authors.lastname: Serdar
authors.forename: N
authors.initials: N
authors.lastname: Ocak
authors.forename: K
authors.initials: K
authors.lastname: Dilek
mesh_terms: D000328:Adult; D001055:Apolipoproteins B / Q000378:metabolism; D043303:Aryldialkylphosphatase / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000150:complications* / Q000378:metabolism*; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000378:metabolism* / Q000628:therapy; D015227:Lipid Peroxidation / Q000502:physiology; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D006435:Renal Dialysis
chemical_list: D001055:Apolipoproteins B; D008315:Malondialdehyde; D043303:Aryldialkylphosphatase